ASX-Dividend-Report-Banner

Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub

May 21, 2024 11:00 PM AEST | By Cision
 Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub
Image source: Kalkine Media

The laboratory gives researchers a training ground for state-of-the-art DNBSEQ technology to further precision diagnostics and treatments

SAN JOSE, Calif., May 21, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced the May 22 opening of its Customer Experience Center (CEC) demonstration lab near Boston's biotech hub.

The new lab, located in Framingham near Boston, is Complete Genomics' first footprint on the East Coast and is expected to enable faster service and support to East Coast customers. Current and prospective customers in Boston and the greater northeast will be able to experience Complete Genomics' DNBSEQ™ workflows including next-generation sequencing platforms, sample prep automation systems and bioinformatics products.

"The opening of our Boston Customer Service Center is the latest example of Complete Genomics' commitment to serve our U.S. customer base. Last week, we celebrated the creation of our first U.S.-based supply chain with the opening of a new $3.2 million manufacturing facility at our San Jose, Calif. headquarters which will be online later this year," said Dr. Radoje (Rade) Drmanac, Co-Founder and Chief Scientific Officer of Complete Genomics.

In addition to an introduction to Complete Genomics and its DNBSEQ sequencing platforms, the event will feature an introduction to the STOmics Stereo-seq technology and a DNBSEQ User Experience Workshop on how to optimize DNBSEQ-G99*, G400*, and T7* sequencers for research projects. A mini symposium will feature several Complete Genomics' ecosystem partnerships centered around DNBSEQ technologies. Speakers from seqWell, Inc., Fluent Biosciences and Velsera, Inc., all headquartered in the Boston area, will present their product solutions and ongoing collaboration with Complete Genomics, aiming for expanded product accessibility to accelerate genomics research.

DNBSEQ sequencing platforms to be featured during the opening event include the flagship DNBSEQ-T7*, the G99*and the E25*. Also featured will be the high-throughput automated sample prep system SP-960 and the eight independent channel pipetting robot SP-Smart 8. The day will wrap up with a tour of the demo lab followed by a cocktail and networking reception. Transportation will be provided from Boston and Cambridge to the lab in Framingham.

Visit www.completegenomics.com/boston-cec-opening for details, including the location, agenda and to RSVP for the event.

About Complete Genomics

Complete Genomics is a pioneering life sciences company that provides novel, end to end DNA sequencing solutions. It has been at the forefront of high throughput cost-effective sequencing technology development since its inception in 2005. Our products have powered over 7,600 publications across a wide array of applications. To learn more, visit www.completegenomics.com.

* For Research Use Only. Not for use in diagnostic procedures.

Media Contact:

Betsy Yates
Complete Genomics
[email protected]

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.